Adequacy of the Comprehensive Clinical Evaluation Program A Focused Assessment (1997) / Chapter Skim
Currently Skimming:
Appendix F
Appendix F
Pages 113-120
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 113... ...
The committee reviewed extensive clinical and research results regarding the effects of nerve agents. No evidence available to the committee conclusively indicated the existence of long-term health effects of low-level exposure to nerve agents.
|
From page 114... ...
Primary physicians could use any of a number of self-report screening scales, but consistent use of the same scale across facilities would ensure consistent results. The committee recommends improved documentation of neurological screening done during both Phase I and Phase II of the CCEP.
|
From page 115... ...
The committee recommends that physicians take more complete patient histories, particularly regarding personal and family histories, the onset of health problems, and occupational and environmental exposures. While there currently is grave concern about exposure to nerve agents during deployment in the Persian Gulf, other factors have an affect on psychological and neurological disorders.
|
From page 116... ...
Such an approach provides an appropriate public health mechanism for imparting information and addressing concerns and should be made available to all Persian Gulf veterans. Although it is beyond the scope of the charge to this committee to determine whether low-level exposure to nerve agents causes long-term health effects, the committee believes strongly that this is an important research area that ought to be pursued.
|
From page 117... ...
The committee emphasizes that the CCEP is not an appropriate vehicle for scientifically assessing questions about long-term health effects of low levels of exposure to nerve agents. The CCEP is a clinical treatment program, not a research protocol.
|
From page 118... ...
Bleecker, Director of the Center for Occupational and Environmental Neurology, Baltimore, Maryland Evelyn J Bromet, Professor, Department of Psychiatry, State University of New York at Stony Brook, Stony Brook, New York Gerard Burrow, Dean, Yale University School of Medicine, New Haven, Connecticut Howard Kipen, Associate Professor and Director, Occupational Health Division, Robert Wood Johnson Medical School, Piscataway, New Jersey Adel A
|
From page 119... ...
Stratton, Director, Division of Health Promotion and Disease Prevention Constance M Pechura, Director, Division of Neuroscience and Behavioral Health 119
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.